Latest filings (excl ownership)
10-Q
2024 Q1
Quarterly report
7 May 24
8-K
Protagonist Reports First Quarter 2024 Financial Results and Provides Corporate Update
7 May 24
ARS
2023 FY
Annual report to shareholders
26 Apr 24
DEFA14A
Additional proxy soliciting materials
26 Apr 24
DEF 14A
Definitive proxy
26 Apr 24
PRE 14A
Preliminary proxy
12 Apr 24
S-8
Registration of securities for employees
27 Feb 24
10-K
2023 FY
Annual report
27 Feb 24
8-K
Protagonist Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
27 Feb 24
8-K
Entry into a Material Definitive Agreement
31 Jan 24
8-K
Other Events
16 Jan 24
8-K
Regulation FD Disclosure
8 Jan 24
10-Q
2023 Q3
Quarterly report
2 Nov 23
8-K
Protagonist Reports Third Quarter 2023 Financial Results and Provides Corporate Update
2 Nov 23
8-K
Departure of Directors or Certain Officers
30 Oct 23
424B5
Prospectus supplement for primary offering
11 Aug 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
8-K
Protagonist Reports Second Quarter 2023 Financial Results and Provides Corporate Update
3 Aug 23
8-K
Other Events
5 Jul 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
3 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
30 May 23
10-Q
2023 Q1
Quarterly report
4 May 23
8-K
Protagonist Reports First Quarter 2023 Financial Results and Provides Corporate Update
4 May 23
ARS
2022 FY
Annual report to shareholders
12 Apr 23
DEFA14A
Additional proxy soliciting materials
12 Apr 23
DEF 14A
Definitive proxy
12 Apr 23
8-K
Other Events
10 Apr 23
424B5
Prospectus supplement for primary offering
5 Apr 23
424B5
Prospectus supplement for primary offering
4 Apr 23
S-8
Registration of securities for employees
15 Mar 23
10-K
2022 FY
Annual report
15 Mar 23
8-K
Protagonist Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
15 Mar 23
8-K
Regulation FD Disclosure
10 Mar 23
8-K
Departure of Directors or Certain Officers
6 Jan 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
8-K
Protagonist Reports Third Quarter 2022 Financial Results and Provides Corporate Update
8 Nov 22
EFFECT
Notice of effectiveness
17 Aug 22
CORRESP
Correspondence with SEC
12 Aug 22
UPLOAD
Letter from SEC
9 Aug 22
S-3
Shelf registration
5 Aug 22
Latest ownership filings
4
Asif Ali
19 Apr 24
4
DINESH V PH D PATEL
2 Apr 24
144
Notice of proposed sale of securities
1 Apr 24
4
HAROLD E SELICK
11 Mar 24
4
DINESH V PH D PATEL
1 Mar 24
4
William D. Waddill
1 Mar 24
4
Asif Ali
1 Mar 24
144
Notice of proposed sale of securities
1 Mar 24
144
Notice of proposed sale of securities
1 Mar 24
144
Notice of proposed sale of securities
1 Mar 24
144
Notice of proposed sale of securities
29 Feb 24
4
DINESH V PH D PATEL
28 Feb 24
4
Suneel Gupta
28 Feb 24
4
DINESH V PH D PATEL
20 Feb 24
SC 13G/A
CITADEL ADVISORS LLC
14 Feb 24
SC 13G/A
BIOTECHNOLOGY VALUE FUND L P
14 Feb 24
SC 13G/A
RTW INVESTMENTS, LP
14 Feb 24
SC 13G/A
Point72 Asset Management, L.P.
14 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
ADAGE CAPITAL PARTNERS GP, L.L.C.
7 Feb 24
SC 13G/A
Farallon Capital Partners, L.P.
2 Feb 24
SC 13G/A
BlackRock Inc.
24 Jan 24
SC 13G/A
STATE STREET CORP
23 Jan 24
4
ARTURO MD MOLINA
18 Jan 24
4
Asif Ali
18 Jan 24
4
Suneel Gupta
11 Jan 24
144
Notice of proposed sale of securities
9 Jan 24
4
William D. Waddill
4 Jan 24
4
Sarah A O'Dowd
4 Jan 24
4
Suneel Gupta
4 Jan 24
4
Lewis T Williams
4 Jan 24
4
HAROLD E SELICK
4 Jan 24
4
DINESH V PH D PATEL
4 Jan 24
4
Bryan Giraudo
4 Jan 24
4
ARTURO MD MOLINA
4 Jan 24
4
Asif Ali
4 Jan 24
SC 13G
Point72 Asset Management, L.P.
18 Dec 23
4
DINESH V PH D PATEL
15 Dec 23
144
Notice of proposed sale of securities
13 Dec 23
4
Daniel N Swisher JR
30 Oct 23